Products
To promote safety in the peptides market, Finnrick is conducting an aggressive program of testing, procuring a total of 8,847 samples from 266 vendors across 15 products and having them checked for purity and quantity in commercial labs.
| Tests | ||||||
|---|---|---|---|---|---|---|
| Product name | Vendors | Count | Avg | Min | Max | Latest |
| Tirzepatide | 176 | 2217 | 1 Jul 2026 | |||
| Semaglutide | 57 | 338 | 1 Jul 2026 | |||
| Retatrutide | 216 | 3230 | 1 Jul 2026 | |||
| BPC-157 | 99 | 675 | 1 Jul 2026 | |||
| CJC-1295 | 53 | 285 | 26 Jun 2026 | |||
| Melanotan II | 39 | 166 | 1 Jul 2026 | |||
| PT-141 | 30 | 110 | 1 Jul 2026 | |||
| Ipamorelin | 60 | 336 | 1 Jul 2026 | |||
| Mazdutide | 10 | 28 | 24 Jun 2026 | |||
| Survodutide | 7 | 27 | 15 Jun 2026 | |||
| Cagrilintide | 22 | 131 | 1 Jul 2026 | |||
| Sermorelin | 7 | 30 | 26 Jun 2026 | |||
| Tesamorelin | 61 | 502 | 1 Jul 2026 | |||
| GHK-Cu | 87 | 651 | 1 Jul 2026 | |||
| TB-500 | 29 | 174 | 1 Jul 2026 | |||